Factors influencing the transition from prediabetes to diabetes on Reunion Island

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on understanding the factors that contribute to the progression from prediabetes to diabetes among the population of Reunion Island, where diabetes prevalence is notably high. It involves a prevention program called 'Say No to Diabetes' aimed at individuals aged 25 to 70 who are diagnosed with prediabetes. Participants will be monitored and surveyed to gather data on their health status and the effectiveness of the intervention. The study seeks to address the urgent health crisis posed by diabetes in this region.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Subject aged 25 to 70 with pre-diabetes defined by fasting blood sugar between 1.10 and 1.25 g / l (6.1 and 6.9 mmol / l) or blood sugar between 1.40 and 1.99 g / l (7.8 and 11.0 mmol / l) 2 hours after taking 75g of glucose (HGPO test), dating from less than 3 months.
* Consulting one of the general practitioners involved in the study, whatever the initial reason for the consultation
* able to answer a telephone survey questionnaire
* who have never been diagnosed or treated for diabetes with the exception of gestational diabetes
* Person affiliated or beneficiary of a social security scheme.
* Free, informed and written consent signed

Exclusion Criteria:

* People likely to leave Reunion within 2 years
* Persons placed under guardianship, curators, safeguard of justice, person participating in another research including an exclusion period still in progress.
* Person with severely impaired physical and / or psychological health, who, according to the investigator, may affect the compliance of the study participant.
* Pregnancy in progress

Where it's running

• Centre Hospitalier Universitaire de la Réunion
  Saint-Pierre, France Recruiting

Study contacts

• Study coordinator: Samir MEDJANE
• Email: samir.medjane@chu-reunion.fr
• Phone: 0262359750

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• New virtual care pathway for older adults with chronic diseases

  A teleconsultation-based care pathway for adults 60+ with hypertension, diabetes, or dyslipidemia to see if it’s feasible and cost-saving in Malaysian primary care compared with usual clinic visits.

  Recruiting National University of Malaysia · Kuala Lumpur · NCT07843238

• Benefits of Retained Insulin for Good Health in Diabetes

  This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.

  Recruiting at 4 sites Royal Devon and Exeter NHS Foundation Trust · Truro, Cornwall and 3 other locations · NCT07828626

• Improving Care for underserved older Black patients with cardiovascular and other chronic conditions

  This study tests a culturally tailored approach to patient-centered care for older African American patients with cardiovascular disease and other conditions who receive care at a community hospital.

  Recruiting University of Alabama at Birmingham · Birmingham, Alabama · NCT07748858

• Myokines in metabolic and endocrine diseases linked to sarcopenia

  This study tests whether myokines can serve as biomarkers or drivers of sarcopenia and sarcopenic obesity in people with metabolic or endocrine diseases.

  Recruiting Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Woluwe-Saint-Pierre - Sint-Pieters-Woluwe · NCT07703683

• Miniature breath sensors to detect hypo- and hyperglycemia in young people with diabetes

  A small breath-sensor device will try to see if specific breath compounds can signal low or high blood sugar in youths with diabetes.

  Recruiting Indiana University · Indianapolis, Indiana · NCT07696273

• Polypill Approach for Multiple Cardiovascular Risk Factors

  Researchers are testing a fixed-dose pill strategy to help people aged 50–75 with high blood pressure, high cholesterol, and diabetes see if it lowers their heart-disease risk and reduces future events.

  Recruiting at 5 sites China Medical University, China · Zhengzhou, Henan and 14 other locations · NCT07679828

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.